Evoke Pharma financials at a glance

+ Portfolio

The revenue of Evoke Pharma is reported as 0.00251 billion Dollars in the fiscal year 2023. The earnings were -2.62 Dollars per share in 2023, which was 19.14 higher than 2021. And about 0 billion Dollars are reported as free cash flow in the financials of Evoke Pharma 2023. No dividends were paid to the shareholders of the Evoke Pharma stock NasdaqCM:EVOK in the financial year 2023.

$2.51M

Revenue

$-2.62

Earnings Per Share

85.24%

Gross Margin %

$0.00M

Free Cash Flow

Revenue

2.51

Earnings Per Share

-2.62

Gross Margin %

85.24

Free Cash Flow

0.00

Financials

Year	Year	TTM	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013
Rev.	Revenue	N/A	$2.51M	$1.62M	$0.02M	$0.00M	$0.00M	$0.00M	$0.00M	$0.00M	$0.00M	$0.00M
GM %	Gross Margin %	92.26%	85.24%	1.29%	-,276.68%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
OM	Operating Margin	-,168.63%	0.00%	-3.68%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
EPS	Earnings Per Share	$-2.28	$-2.62	$-3.24	$-6.24	$-3.84	$-5.52	$-9.60	$-13.80	$-22.44	$-26.40	$-14.40
Div.	Dividends	N/A	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
PR %	Payout Ratio %	0	0	0	0	0	0	0	0	0	0	0
Sha.	Shares	N/AM	3.34M	2.74M	2.7M	2.04M	1.45M	1.28M	1.03M	0.59M	0.51M	0.5M
OCF	Operating Cash Flow	N/A	$0.00M	$0.00M	$0.00M	$0.00M	$0.00M	$-8.72M	$-8.71M	$-10.50M	$-11.50M	$-3.04M
FCF	Free Cash Flow	N/A	$0.00M	$0.00M	$0.00M	$0.00M	$0.00M	$-8.72M	$-8.71M	$0.00M	$-11.50M	$0.00M
FCFS	Free Cash Flow Per Share	$-1.91	$-2.10	$-4.61	$-0.26	$-0.26	$-0.42	$-0.59	$-0.93	$-1.62	$-1.91	$-1.28

Evoke Pharma financials at a glance

Financials

Discover